A packaging defect has led to Merck voluntarily recalling all lots of Liptruzet tablets in the United States.

An optical sensor designed by chemists at the Massachusetts Institute of Technology tracks zinc levels to gain insight on prostate cancer.

SGS will open its fifth Life Sciences Services Laboratory in Carson, California.

USP announced the approval of General Notices section 5.60.30 Elemental Impurities in USP Drug Products and Dietary Supplements with an official date of Dec. 1, 2015.

MedImmune has entered into a research collaboration with Immunocore to develop novel cancer therapies.

FDA releases guidance on the qualification of drug development tools.

Research was published describing a natural interferon-alpha for infection control and treatment of drug-resistant H7N9 influenza.

Forest's planned acquisition of Aptalis will enhance its business in gastrointestinal and cystic fibrosis therapies.

Eurofins acquires DDS business of Merck KGaA in order to expand discovery solutions and bioanalytical services.

Ron Piervincenzi to assume leadership of the United States Pharmacopeial Convention on Feb. 1, 2014.

EMA has launched a new version of the EudraGMDP database, which includes the publication of statements of non-compliance with good manufacturing practice.

GE acquires Thermo Fisher's HyClone cell culture media and sera products, gene modulation technologies, and magnetic beads businesses.

A study led by Stanford University explains why men may have weaker responses to vaccines than women.

A monkey-vaccine study provides insight into HIV research.

Roche?s Brain Shuttle technology transfers antibodies through the BBB.

Mac Process will merge with Schenck AccuRate and combine their operations under the name of Schenck Process.

Generics, market dynamics, and global demand are changing drug spending patterns.

Janssen's donation program will improve access to the company's approved HIV medicines for children and adolescents in sub-Saharan Africa.

Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator.

Former US President Jimmy Carter and Pfizer commemorate the 15th anniversary of the International Trachoma Initiative to end blinding trachoma by the year 2020.

Training, calibration, and preventive maintenance help prevent over-and under-weight tablets. The author discusses causes of off-weight tablets and best practices for tableting.

The Bristol-Myers Squibb Foundation is awarding 10 grants to fund programs for veterans and their families.

With SMEs gaining wider recognition as the powerhouse of research and innovation in Europe, regulatory agencies are urging companies to engage with regulators early in the drug-development process.

Genzyme plans to appeal FDA?s decision that the multiple-sclerosis treatment is not ready for approval.

Abrams Royal Pharmacy is recalling all unexpired lots of sterile products dispensed in the US.

Baxter International recalls dextrose injection and four sodium chloride injections.

Supernus Pharmaceuticals receives FDA approval of Orenitram for the treatment of pulmonary arterial hypertension.

This month, healthcare leaders from six of the world's top 20 pharmaceutical companies met together in collaboration with the Oliver Wyman Health Innovation Center to explore the industry's changing role in today's value-basaed healthcare structure.